Cubist Systematic Strategies’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$524K Sell
2022
Q3
$600K Sell
2022
Q2
$593K Buy
2022
Q1
$250K Buy